American Century Companies’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

American Century Companies’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-40,584	Closed	-$1.51M	–	2372
2021 Q2	$1.51M	Buy	40,584 +719	+2%	+$22K	﹤0.01%	1383
2021 Q1	$1.02M	Buy	39,865 +29,928	+301%	+$764K	﹤0.01%	1414
2020 Q4	$219K	Buy	+9,937	New	+$219K	﹤0.01%	1847
2020 Q1	–	Sell	-16,618	Closed	-$366K	–	1759
2019 Q4	$366K	Sell	16,618 -123,065	-88%	-$2.48M	﹤0.01%	1248
2019 Q3	$2.01M	Sell	139,683 -54,847	-28%	-$784K	﹤0.01%	968
2019 Q2	$3.06M	Buy	+194,530	New	+$2.65M	﹤0.01%	943

Other funds holding DRNA

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

American Century Companies's DRNA Position: Q3 2021 in Review

American Century Companies sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q3 2021, closing a stake of 40,584 shares — an estimated $1.51M sold.

American Century Companies first reported a position in DRNA in Q2 2019 and held it in 6 quarters. The position peaked at $3.06M in Q2 2019. 173 funds tracked by Wall St. Rank hold DRNA as of Q3 2021.

American Century Companies reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
American Century Companies sold 40,584 Dicerna Pharmaceuticals, Inc. shares in Q3 2021, an estimated $1.51M.
American Century Companies first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2019 and held it in 6 quarters.
American Century Companies's Dicerna Pharmaceuticals, Inc. position peaked at $3.06M in Q2 2019.
173 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q3 2021.

Based on American Century Companies's 13F filing for Q3 2021, filed 10 Nov 2021.